Our combination of practice excellence and deep industry expertise provides a distinct competitive advantage to our clients, bringing together legal expertise, commercial insight and close professional support.
Law-Now Zones provide expert analysis on specialist topics
For analysis and commentary on the impact of Brexit on businesses operating in, and trading with, the UK
Issue 6 | Summer 2016
Summarising the challenges facing the sector today and the possible solutions offered to help you overcome them.
Looking at the key trends from 2015 and the implications for the year ahead.
Welcome to the home of lifesciences – regulation on Law-Now.
On this page, you will find all the articles and publications for lifesciences regulation.
To stay in touch with the latest developments, please bookmark this page on your mobile or register to receive eAlerts.
Administrative Measures for Drug Registration (Draft Revision) issued by CFDA, 25 July
The China Food and Drug Administration (CFDA) has released the...
Le cabinet De Block l’annonçait : l’informatisation des hôpitaux et la mise en œuvre de la feuille de route eSanté constituent des priorités politiques....
The Hungarian Secretary of State for Health recently announced that starting in autumn 2016 a uniform contract template issued by the National Healthcare...
CMS London has contributed to GCR Know-How’s Antimonopoly and Unilateral Conduct 2016 publication, which looks at, in particular, how companies with strong...
The British people have voted to leave the European Union.
No European Union Member State has left the EU so the process of withdrawal is untested. Effecting...
Welcome to the Summer 2016 edition of The Antidote, our lifesciences sector bulletin.
In this edition, we look at:
the new Market Abuse Regulation...
With only days to go to the EU referendum in the UK, we have devised 50 questions with suggested answers and resources. EU membership affects our work...
On February 2nd 2016, CMS hosted a conference on key trends in the lifesciences sector and the outlook for 2016.
A keynote speaker from the Association...
There have been no recent searches.
Analysis and commentary
What are the legal issues for the lifesciences sector following a Brexit? Read CMS’ Lifesciences checklist to help guide you through what a Brexit could really mean for your business
© CMS Legal 2016